Pitfalls in efficacy testing – how important is the validation of neutralization of chlorhexidine digluconate? by Reichel, Mirja et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
Annals of Clinical Microbiology and 
Antimicrobials
Open Access Research
Pitfalls in efficacy testing – how important is the validation of 
neutralization of chlorhexidine digluconate?
Mirja Reichel*1,2, Peter Heisig2 and Günter Kampf1,3
Address: 1Bode Chemie GmbH & Co, KG, Scientific Affairs, Melanchthonstr. 27, 22525, Hamburg, Germany, 2Department of Pharmaceutical 
Biology and Microbiology, Institute of Pharmacy, University of Hamburg, Hamburg, Germany and 3Institute for Hygiene and Environmental 
Medicine, Ernst Moritz Arndt University, Walther-Rathenau-Str. 49a, 17475, Greifswald, Germany
Email: Mirja Reichel* - mirja.reichel@bode-chemie.de; Peter Heisig - heisig@chemie.uni-hamburg.de; Günter Kampf - guenter.kampf@bode-
chemie.de
* Corresponding author    
Abstract
Background: Effective neutralization of active agents is essential to obtain valid efficacy results,
especially when non-volatile active agents like chlorhexidine digluconate (CHG) are tested. The aim
of this study was to determine an effective and non-toxic neutralizing mixture for a propan-1-ol
solution containing 2% CHG.
Methods:  Experiments were carried out according to ASTM E 1054-02. The neutralization
capacity was tested separately with five challenge microorganisms in suspension, and with a rayon
swab carrier. Either 0.5 mL of the antiseptic solution (suspension test) or a saturated swab with
the antiseptic solution (carrier test) was added to tryptic soy broth containing neutralizing agents.
After the samples were mixed, aliquots were spread immediately and after 3 h of storage at 2 –
8°C onto tryptic soy agar containing a neutralizing mixture.
Results: The neutralizer was, however, not consistently effective in the suspension test. Immediate
spread yielded a valid neutralization with Staphylococcus aureus, Staphylococcus epidermidis and
Corynebacterium jeikeium but not with Micrococcus luteus (p < 0.001) and Candida albicans (p < 0.001).
A 3-h storage period of the neutralized active agents in suspension resulted in significant carry-over
activity of CHG in addition against Staphylococcus epidermidis (p < 0.001) and Corynebacterium
jeikeium (p = 0.044). In the carrier test, the neutralizing mixture was found to be effective and non
toxic to all challenge microorganisms when spread immediately. However, after 3 h storage of the
neutralized active agents significant carry-over activity of CHG against Micrococcus luteus (p = 0.004;
Tukey HSD) was observed.
Conclusion: Without effective neutralization in the sampling fluid, non-volatile active ingredients
will continue to reduce the number of surviving microorganisms after antiseptic treatment even if
the sampling fluid is kept cold straight after testing. This can result in false-positive antiseptic efficacy
data. Attention should be paid during the neutralization validation process to the amount of
antiseptic solution, the storage time and to the choice of appropriate and sensitive microorganisms.
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Background
Different alcohols such as propan-1-ol, propan-2-ol and
ethanol as well as chlorhexidine digluconate (CHG) have
been used as effective antiseptic agents for many years.
One of the main properties of CHG is its residual antimi-
crobial activity which is beneficial in skin antiseptics used
for catheter care [1] but not in hand hygiene [2]. Combi-
nations of CHG and an alcohol have an advantage over
single compounds. For example, the benefits of combin-
ing these substances include the immediate reduction of
bacterial density by alcohols and the prolonged antibacte-
rial effect of CHG.
The use of CHG, which has been shown to be superior to
other skin antiseptics in preventing catheter-related
bloodstream infections [1], is recommended by the Cent-
ers for Disease Control and Prevention (CDC) for skin
antisepsis of catheter insertion sites [3]. The use of 2%
CHG-based preparations before catheter insertion and
during dressing changes is "strongly recommended for
implementation and strongly supported by well-designed
experimental, clinical, or epidemiologic studies" [3]. This
recommendation is based on various studies which show
that the incidence of catheter-associated primary blood-
stream infection can be significantly reduced when CHG
is used for treatment of the catheter insertion site [1].
The "residual effect" of CHG in hand hygiene prepara-
tions, however, is not measured in the same way. This is
commonly determined by measuring the reduction of
bacterial density, e.g. on fingertips [4,5] or hands [6].
In order to achieve valid results of practical relevance on
the efficacy of skin antiseptics and hand disinfectants,
they are usually tested in vitro and under practical condi-
tions in healthy volunteers.
The main objective of efficacy tests is to determine the
number of surviving microorganisms after a specific con-
tact time measured at a defined time point. Therefore, the
continuation of the antimicrobial effects of an antiseptic
after the chosen contact time must be excluded by com-
plete inactivation of the antimicrobial substances at this
specific time. This process results in quenching the anti-
microbial activity of a formulation and is defined as neu-
tralization by the American Society for Testing and
Materials (ASTM) [7].
In efficacy studies without neutralization in the sampling
fluid, the number of surviving microorganisms is often
remarkably low suggesting a high efficacy of CHG [8-10].
However, this effect can not be explained by efficacy dur-
ing the exposure time but is achieved by continuous anti-
microbial activity after the exposure time [9]. That is why
the credibility of antimicrobial efficacy results depend
largely on the performance of validated neutralization
[10], especially when non-volatile active agents like CHG
are tested [9,11].
One crucial point in neutralization evaluation and valida-
tion is the comparability of the in vitro neutralizer test and
the effectiveness evaluation under practical conditions
[12]. In this process all relevant critical parameters of the
antiseptic test should be taken into the neutralizer valida-
tion process such as different and relevant types of micro-
organisms and carriers as well as storage conditions used
in the efficacy test.
Even though the recently published guidelines for anti-
septic efficacy tests require different forms of neutraliza-
tion [13,14] and neutralization validation [15], many of
the efficacy data from published studies were obtained
either without adequate neutralization, without validated
neutralization or without specification of the neutralizing
process (e.g. storage time and temperature) and the vali-
dation status [2,16,17].
For the validation of neutralization, a European norm
[18] as well as an ATSM standard [7] are available. Both of
these methods focus on the effectiveness of the neutralizer
on the one hand and the toxicity to test organisms on the
other. Both methods describe different forms of neutrali-
zation.
The ASTM E 1054-02 method encourages the use of all
microorganisms of the efficacy test also in the neutraliza-
tion assay. The investigator is allowed to select the appro-
priate, representative microorganisms for the efficacy test
[7].
In contrast, the European norm (EN) 13727 requires the
use of four different test organisms (Escherichia coli (k12)
NCTC 10538, Pseudomonas aeruginosa ATCC 15442, Sta-
phylococcus aureus ATCC 6538 and Enterococcus hirae ATCC
10541) which may not always be appropriate for the effi-
cacy evaluation [18]. Due to the fact that this norm is
designed for in vitro suspension tests and not for in vivo
tests, and that different microorganisms show different
sensitivity to the carry-over effect of antiseptics, this
choice of species may not be suitable for the validation of
neutralization for specific tests such as skin antiseptics.
However, there is no other comparable standard available
besides the above mentioned ASTM method, which is
obligatory for the ASTM test of skin antiseptics [19] and
which includes the validation of neutralization.
In the present study, neutralization validation by chemi-
cal inhibition using an alcoholic solution containing 2%
CHG was carried out using 5 bacterial species relevant forAnnals of Clinical Microbiology and Antimicrobials 2008, 7:20 http://www.ann-clinmicrob.com/content/7/1/20
Page 3 of 7
(page number not for citation purposes)
skin antisepsis and which were, with the exception of Sta-
phylococcus aureus, not part of the EN.
The aim of this study was to determine whether the valid-
ity of neutralization was influenced by the type of test
(suspension test versus carrier test), by the type of micro-
organism or by different storage times of the neutralized




A solution containing 89.5% (v/v) propan-1-ol and 2%
(w/w) CHG, manufactured by Bode Chemie GmbH & Co.
KG, Hamburg, Germany, was used in this study. The con-
centrations of the active agents were checked prior to val-
idation by gas chromatography (propan-1-ol) and
ultraviolet spectroscopy (CHG). The allowed tolerance
was defined as 1% relative to the propan-1-ol concentra-
tion and 3% relative to the concentration of CHG.
Test organisms
Five clinically relevant species, all found on human skin,
were tested separately: Staphylococcus aureus ATCC 6538;
Staphylococcus epidermidis ATCC 12228, Micrococcus luteus
ATCC 4698, Corynebacterium jeikeium ATCC 43734, and
Candida albicans ATCC 10231.
Neutralizing agents
The following neutralizing agents were used:
￿ In tryptic soy broth: 3% polysorbate 80, 0.3% lecithin,
0.1% L-histidine, 0.5% sodium thiosulfate, 3% saponine
and 1% ether sulfate. The suitability of these agents has
been described previously [2]
￿ In tryptic soy agar: 0.1% L-histidine, 0.3% lecithin and
3% polysorbat 80.
Test procedure
Experiments were carried out according to ASTM E 1054-
02 "Neutralization Assay with Recovery on Solid
Medium" [7].
Inocula were prepared by transferring microorganisms
from stock cultures onto tryptic soy agar plates containing
neutralizer which were incubated for 24 – 48 h at 37 ±
2°C. A second passage was generated under similar condi-
tions. Microorganisms were suspended in saline peptone
water, transferred into sterile flasks and stirred for about
10 minutes. Aliquots of selected dilutions were used for
the test to ensure a microbial density of about 30 – 100
colony-forming units (CFU) in 1 mL of sampling fluid
based on an initial volume of 5 mL.
Neutralizer effectiveness test
The neutralizer effectiveness tests were performed in two
ways: with a rayon swab carrier and in suspension without
carrier with 5 mL of tryptic soy broth containing the neu-
tralizing agents.
￿ Carrier test:
The rayon swab carrier (BBL CultureSwab, Sterile, Becton
Dickinson GmbH, Heidelberg, Germany) was placed in
2.5 mL of the antiseptic solution; after 20 s the swab was
taken out of the antiseptic solution and the tip of the sat-
urated swab was broken off and placed into the broth
(amount of the antiseptic solution on the saturated swab:
approx. 0.14 mL, measured as the difference in volume
between a dry swab and a completely saturated swab)
￿ Suspension test:
0.5 mL of the antiseptic solution was added to 5 mL of
broth.
Neutralizer toxicity test
The test organism was added to 5 mL of saline peptone
water containing the neutralizing mixture.
Organism viability test
The test organism was added to 5 mL of saline peptone
water without the neutralizing mixture.
Material control test
The test organism was added to 5 mL of the antiseptic
solution.
In all tests, the sample was mixed and within 5 s an aliq-
uot of the test organism was added.
After addition of the test organism, the samples were
mixed for 30 s and:
1. within one minute, aliquots were plated in duplicate
2. after 3 h storage at 2 – 8°C, aliquots were plated in
duplicate (to simulate the longest possible exposure
period in the antimicrobial efficacy test).
Tryptic soy agar plates containing the neutralizing agents
were used in the effectiveness tests as well as in the toxicity
tests. For the detection of organism viability and material
control, tryptic soy agar without neutralizer was used as a
solid medium. After incubation (aerobically, 48 h at 37 ±
2°C) the number of CFU was counted, the mean number
of CFU in both plates was calculated and transformed to
a log10-value.Annals of Clinical Microbiology and Antimicrobials 2008, 7:20 http://www.ann-clinmicrob.com/content/7/1/20
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Statistical analysis
Each experiment was carried out in triplicate. The results
were evaluated as arithmetic means of the log10-values. An
analysis of variance between the tests (neutralizer toxicity,
material control, organism viability and neutralizer effec-
tiveness) was performed for each microorganism. In the
event of a significant difference (p < 0.05) being observed,
a post-hoc test (Tukey-HSD) was carried out. Two criteria
had to be met to categorize the neutralization as invalid:
The difference in the means between the neutralizer effec-
tiveness test and the organism viability test must be
1: significant in post-hoc analysis, and
2: > 0.2 log10-steps (defined limit of biological relevance)
Besides the direct comparison with the organism viability
test, we calculated the difference between the CFU [log10]
after 3 h storage and that of the immediate spread samples
and compared the means of these differences for each rep-
licate and each microorganism.
Results
The neutralizing agents showed no toxicity even after 3 h
storage time. The antiseptic solution was active against all
challenge microorganisms after a short time as well as
after 3 h of storage (Table 1). In all cases, no microorgan-
isms survived the material control test which resulted in
significant differences in comparison to the organism via-
bility test (p < 0.001) indicating that the antiseptic solu-
tion had strong activity against all five organisms tested.
In the suspension test (Table 2), after the short storage
time, the neutralized antiseptic agent was capable of sig-
nificantly reducing the number of Micrococcus luteus CFU
(p < 0.001; Tukey-HSD) and Candida albicans CFU (p <
0.001) in comparison to the organism viability test. After
3 h of storage, four of five neutralizations in the suspen-
sion test failed (Staphylococcus epidermidis, p < 0.001,
Micrococcus luteus p < 0.001, Candida albicans, p < 0.001
and Corynebacterium jeikeium, p = 0.044).
The results of the carrier test showed that no validation
failed in the neutralizer effectiveness test after immediate
spreading (Table 3). After 3 h of storage, the number of
Micrococcus luteus CFU decreased (Figure 1) which
resulted in a significant difference in comparison to the
number of CFU in the organism viability test (p = 0.004).
In four cases in the suspension test and one case in the car-
rier test, the number of surviving microorganisms
decreased within the 3-hour storage period. Figure 1
shows the differences between the means for the 3-h
stored samples and the immediate spread samples.
The highest decrease in cell number was found in the sus-
pension test with Candida albicans (Δ of mean of CFU
[log10] = -0.92, p = 0.004, t-test), followed by Staphylococ-
cus epidermidis (Δ of mean of CFU [log10] = -0.91, p =
0.006). In spite of these significant differences in compar-
ison to the organism viability test, the differences were not
significant when compared with Corynebacterium jeikeium.
Due to the fact that Micrococcus luteus was reduced to
below the limit of detection within one minute of the con-
tact time, no further reduction was detected after storage
for 3 h. When a carrier was used, the CFU [log10] counts of
Micrococcus luteus decreased within the 3-h storage period,
however, this decrease was not statistically significant.
Table 1: Determination of neutralizer toxicity, material antiseptic activity and organism viability according to ASTM E 1054-02.
Storage 
time
Test organism exposed to 











< 1 min neutralizer in saline peptone water 
(neutralizer toxicity test)
1.86 ± 0.05 1.81 ± 0.03 1.77 ± 0.01 1.82 ± 0.02 2.05 ± 0.01
antiseptic solution 
(material control test)
0* 0* 0* 0* 0*
saline peptone water 
(organism viability test)
1.90 ± 0.05 1.84 ± 0.07 1.74 ± 0.03 1.79 ± 0.02 2.02 ± 0.03
3 h neutralizer in saline peptone water 
(neutralizer toxicity test)
1.83 ± 0.02 1.81 ± 0.02 1.72 ± 0.03 1.89 ± 0.08 2.05 ± 0.06
antiseptic solution 
(material control test)
0* 0* 0* 0* 0*
saline peptone water 
(organism viability test)
1.88 ± 0.06 1.81 ± 0.02 1.73 ± 0.05 1.77 ± 0.08 2.03 ± 0.02
Mean and SD of the number of CFU (log10) when exposed to the neutralizer in saline peptone water, the antiseptic solution or saline peptone 
water at storage times of < 1 min and 3 h; * significant difference (p < 0.05) in comparison to organism viability test, Tukey-HSDAnnals of Clinical Microbiology and Antimicrobials 2008, 7:20 http://www.ann-clinmicrob.com/content/7/1/20
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Discussion
We were able to show for the first time that the validation
of neutralization is strongly influenced by the amount of
active agents, the amount of neutralizing agents, the stor-
age time of the neutralized antiseptic before plating and
by the chosen microorganism.
The need for neutralization validation as a basis of antimi-
crobial efficacy evaluations was emphasized by the fact
that in studies without neutralizing agents in the sampling
fluid, the efficacy of CHG was remarkably higher than in
studies with neutralization [9,10]. A major limitation of
many studies regarding the efficacy of antiseptic products
is that the neutralization process is not specified at all. It
is often not described if the active antimicrobial agents
were neutralized, if the neutralization was validated and if
the validation procedure followed the conditions of the
efficacy evaluation [2].
One critical point in neutralization validation is the ratio
between the amount of antiseptic agent and the amount
of neutralizing agents available. In our study, 0.5 mL of
antiseptic agents were mixed with 5 mL of broth contain-
ing the neutralizing agents, and 0.14 mL of antiseptic
agents were mixed with 5 mL of broth containing the neu-
tralizing agents in the carrier tests, this resulted in about
three times more antiseptic solution in the suspension test
than in the carrier test. After the short exposure time of <
1 min, neutralization failed with Micrococcus luteus and
Candida albicans in the suspension test whereas neutraliza-
tion was valid with all five test organisms in the carrier
test. After 3 h storage of the neutralized antiseptic, the dif-
ference between the carrier tests and the suspension tests
became more obvious. Neutralization failed in the sus-
pension test with four of the five organisms tested, but
only one failed (Micrococcus luteus) when the small
amount of antiseptic solution was added in the carrier
test. Whether the results depended on the type of test (car-
rier or suspension) could not be determined with this
study design because equal amounts of the antiseptic
solution were not compared in the two tests. There is
some evidence in the literature which suggests a possible
interaction between CHG and fibres such as cotton, there-
fore, we can not exclude the possibility that the swab
material may have influenced the test results [20].
Based on our data it appears reasonable to conclude that
validation of neutralization is acceptable for a carrier test
if the experimental evidence is obtained from a suspen-
sion test and the amount of antiseptic solution in the car-
Table 2: Suspension test for validation of neutralization of chlorhexidine digluconate.
Storage 
time
Test organism exposed to 











<1 min. neutralized antiseptic solution 
(neutralizer toxicity test)
1.82 ± 0.04 1.77 ± 0.03 0* 1.66 ± 0.09 1.06 ± 0.12*
saline peptone water 
(organism viability test)
1.90 ± 0.05 1.84 ± 0.07 1.74 ± 0.03 1.79 ± 0.02 2.02 ± 0.03
3 h neutralized antiseptic solution 
(neutralizer toxicity test)
1.80 ± 0.02 0.86 ± 0.14* 0* 1.44 ± 0.22* 0.13 ± 0.23*
saline peptone water 
(organism viability test)
1.88 ± 0.06 1.81 ± 0.02 1.73 ± 0.05 1.77 ± 0.08 2.03 ± 0.02
Mean and SD of the number of CFU (log10) when exposed to the neutralized antiseptic solution or saline peptone water at storage times of < 1 min 
and 3 h; * significant difference (p < 0.05) in comparison to organism viability test, Tukey-HSD
Table 3: Carrier test for validation of neutralization of chlorhexidine digluconate.
Storage 
time
Test organism exposed to 











<1 min. neutralized antiseptic solution 
(neutralizer toxicity test)
1.84 ± 0.01 1.83 ± 0.04 1,61 ± 0.05 1.84 ± 0.01 2.02 ± 0.03
saline peptone water 
(organism viability test)
1.90 ± 0.05 1.84 ± 0.07 1.74 ± 0.03 1.79 ± 0.02 2.02 ± 0.03
3 h neutralized antiseptic solution 
(neutralizer toxicity test)
1.87 ± 0.01 1.87 ± 0.01 1.44 ± 0.14* 1.91 ± 0.08 2.10 ± 0.04
saline peptone water 
(organism viability test)
1.88 ± 0.06 1.81 ± 0.02 1.73 ± 0.05 1.77 ± 0.08 2.03 ± 0.02
Mean and SD of the number of CFU (log10) when exposed to the neutralized antiseptic solution or saline peptone water at storage times of < 1 min 
and 3 h; * significant difference (p < 0.05) in comparison to organism viability test, Tukey-HSDAnnals of Clinical Microbiology and Antimicrobials 2008, 7:20 http://www.ann-clinmicrob.com/content/7/1/20
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rier test is at least equal or less than that in the suspension
test. Nevertheless, simulation of the efficacy test condi-
tions as close as possible in the validation process is pre-
ferred.
Another critical point in neutralization validation is the
storage time of neutralized antiseptic products. We were
able to show that validation of neutralization is possible
after a short storage time of the neutralized antiseptic
product (< 1 min). If the neutralized antiseptic product,
however, is stored for 3 h at 2 – 8°C, it may continue to
kill microorganisms resulting in a lower number of surviv-
ing test organisms. If in an efficacy test of an antiseptic
product, neutralization validation is performed with a
very short storage time after sampling, and the efficacy test
itself has a long storage time after sampling, this may well
result in a lower number of surviving test organisms indi-
cating better efficacy of the antiseptic product which could
be classified as a false-positive efficacy result. Based on our
data it is important that the storage time in the efficacy test
is not longer than the storage time in the neutralization
validation.
One parameter which has been overlooked so far, espe-
cially in the EN, is the impact of test organism choice on
the outcome of neutralization and neutralization valida-
tion. To our knowledge this is the first study to show the
importance of the type of microorganism in the validation
process which is relevant for the subsequent efficacy eval-
uation. Based on our results it is not advisable to draw
conclusions regarding the effectiveness of a neutralizer if
different microorganisms are used in the validation proc-
ess than in the efficacy evaluation. The efficacy of skin
antiseptics is commonly determined using mixed skin
flora on different skin sites (e.g. abdominal skin, groin,
forehead, arms) [15,21]. If neutralization validation of a
skin antiseptic is only determined using Staphylococcus
aureus, the overall efficacy of the skin antiseptic could be
overestimated because it is possible that other resident
microorganisms such as Micrococcus luteus, which is more
Delta of mean of CFU (log) between 3 h storage and immediate spread of neutralized antiseptic solution Figure 1
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sensitive to residual CHG, will still be affected in the effi-
cacy evaluation despite "valid neutralization".
In general the validation conditions should simulate the
efficacy test conditions as closely as possible. With regard
to all the challenge microorganisms used in this study,
Micrococcus luteus was the most sensitive test organism and
appears therefore to be appropriate for the sensitive detec-
tion of neutralizer validity.
Conclusion
Valid neutralization during testing is essential for the sci-
entific assessment of antiseptic efficacy in a defined con-
tact time. Without valid neutralization false-positive
efficacy data are likely. The design of the validation proc-
ess should closely follow the design of the efficacy test.
Attention should be paid in the validation process to the
amount of antiseptic solution, the storage time and to the
choice of appropriate and sensitive microorganisms.
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